Korean Food and Drug Administration (KFDA) officials gave an overall audit for Clarithromycin on 11th April, 2011. GMP status, Validation of API, and all documentation etc., have been checked during the two days inspection. Based on our dedicated workshop, high level facilities, and full preparation for required documentation and records, Better Pharma smoothly obtained the audit approval for Clarithromycin to Korean Market.